Hillhouse Capital Management - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 46 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.69 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2018$2,491,000
-38.3%
715,704
-10.8%
0.04%
-40.8%
Q1 2018$4,035,000
-15.9%
802,1740.0%0.07%
-12.3%
Q4 2017$4,797,000
-27.0%
802,1740.0%0.08%
-25.7%
Q3 2017$6,570,000–802,174–0.11%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q1 2018
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders